Skip to main content
SpringerLink
Log in

Kaposi’s Sarcoma

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments

  • 24 Accesses

Abstract

Kaposi’s sarcoma (KS) is a multifocal tumor of lymphatic endothelial cell origin associated with human type 8 herpesvirus (HHV-8). Four variants of KS (classic, endemic African, epidemic HIV-related, and iatrogenic type) are recognized and characterized by different epidemiological and clinical features as well as biological behavior but similar histopathological findings. Clinical staging is extremely important to guide the treatment choice. Therapeutic approaches are chosen on the basis of the extent of lesions and the involvement of internal organs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Further Reading

  • Bodsworth NJ, Bloch M, Bower M, Donnell D, Yocum R. International panretin Gel KS Study Group phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi’s sarcoma. Am J Clin Dermatol. 2001;2:77–87.

    Article  CAS  PubMed  Google Scholar 

  • Brambilla L, Bellinvia M, Tourlaki A, Scoppio B, Gaiani F, Boneschi V. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients. Br J Dermatol. 2010;62:854–9.

    Article  Google Scholar 

  • Caccialanza M, Marca S, Piccinno R, Eulisse G. Radiotherapy of classic and human immunodeficiency virus-related Kaposi’s sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol. 2008;22:297–302.

    Article  CAS  PubMed  Google Scholar 

  • Célestin Schartz NE, Chevret S, Paz C, Kerob D, Verola O, Morel P, Lebbé C. Imiquimod 5% cream for treatment of HIV-negative Kaposi’s sarcoma skin lesions: a phase I to II, open-label trial in 17 patients. J Am Acad Dermatol. 2008;58:585–91.

    Article  PubMed  Google Scholar 

  • Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nat Rev Dis Primers. 2019;5:9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immuno-deficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010;116:3969–77.

    Article  PubMed  Google Scholar 

  • Delyon J, Bizot A, Battistella M, et al. PD-1 blockade with nivolumab in endemic Kaposi sarcoma. Ann Oncol. 2018;29:1067–9.

    Article  CAS  PubMed  Google Scholar 

  • Di Lorenzo G, Kreuter A, Di Trolio R, Guarini A, Romano C, Montesarchio V, Brockmeyer NH, De Placido S, Bower M, Dezube BJ. Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi’s sarcoma: a multicenter study. J Invest Dermatol. 2008;128:1578–80.

    Article  PubMed  Google Scholar 

  • Di Monta G, Caracò C, Benedetto L, La Padula S, Marone U, Tornesello ML, Buonaguro FM, Simeone E, Ascierto PA, Mozzillo N. Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi’s sarcoma. Eur J Surg Oncol. 2014;40:61–6.

    Article  PubMed  Google Scholar 

  • Díaz-Ley B, Grillo E, Ríos-Buceta L, Paoli J, Moreno C, Vano-Galván S, Jaén-Olasolo P. Classic Kaposi’s sarcoma treated with topical rapamycin. Dermatol Ther. 2015;28:40–3.

    Article  PubMed  Google Scholar 

  • Donato V, Guarnaccia R, Dognini J, de Pascalis G, Caruso C, Bellagamba R, Morrone A. Radiation therapy in the treatment of HIV-related Kaposi’s sarcoma. Anticancer Res. 2013;33:2153–7.

    CAS  PubMed  Google Scholar 

  • Elder DE, Massi D, Scolyer R, Willemze R, editors. WHO classification of skin tumours. 4th ed. International Agency for Research on Cancer; 2018.

    Google Scholar 

  • Ertürk Yılmaz T, Akay BN, Heper AO. Dermoscopic findings of Kaposi sarcoma and dermatopathological correlations. Australas J Dermatol. 2020;61:e46–53.

    Article  PubMed  Google Scholar 

  • Galanina N, Goodman AM, Cohen PR, et al. Successful treatment of HIV-associated Kaposi sarcoma with immune checkpoint blockade. Cancer Immunol Res. 2018;6:1129–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Grulich AE, Vajdic CM. The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol. 2015;42:247–57.

    Article  PubMed  Google Scholar 

  • Gupta R, DeBord L, Dao H Jr. Failed treatment of classic Kaposi’s sarcoma with topical timolol: case report and review of the literature. Cureus. 2019;11:e6272.

    PubMed  PubMed Central  Google Scholar 

  • Krown SE, Moser CB, MacPhail P, Matining RM, Godfrey C, Caruso SR, Hosseinipour MC, Samaneka W, Nyirenda M, Busakhala NW, Okuku FM, Kosgei J, Hoagland B, Mwelase N, Oliver VO, Burger H, Mngqibisa R, Nokta M, Campbell TB, Borok MZ. A5263/AMC066 protocol team. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomized, non-inferiority trial. Lancet. 2020a;395:1195–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krown SE, Moser CB, MacPhail P, Matining RM, Godfrey C, Caruso SR, Hosseinipour MC, Samaneka W, Nyirenda M, Busakhala NW, Okuku FM, Kosgei J, Hoagland B, Mwelase N, Oliver VO, Burger H, Mngqibisa R, Nokta M, Campbell TB, Borok MZ. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet. 2020b;395:1195–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kutlubay Z, Küçüktaş M, Yardımcı G, Engin B, Serdaroğlu S. Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi’s sarcoma. Dermatol Surg. 2013;39:1502–6.

    Article  CAS  PubMed  Google Scholar 

  • Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ. Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy. AIDS. 2013;27:635–43.

    Article  PubMed  Google Scholar 

  • Martin-Carbonero L, Barrios A, Saballs P, Sirera G, Santos J, Palacios R, et al. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi’s sarcoma. AIDS. 2004;18:1737–40.

    Article  CAS  PubMed  Google Scholar 

  • Pagliarello C, Stanganelli I, Fabrizi G, Feliciani C, Di Nuzzo S. Topical diphencyprone immunotherapy for painful nodular acral recurrence of Kaposi sarcoma. JAMA Dermatol. 2017;153:234–5.

    Article  PubMed  Google Scholar 

  • Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ. Cancer in Africa 2018: the role of infections. Int J Cancer. 2020;146:2089–103.

    Article  CAS  PubMed  Google Scholar 

  • Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, et al. Pomalidomide for symptomatic Kaposi’s sarcoma in people with and without HIV infection: a phase I/II study. J Clin Oncol. 2016;34:4125–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D. Phase II trial of lenalidomide in HIV-infected patients with previously treated Kaposi’s sarcoma: results of the ANRS 154 Lenakap trial. AIDS Res Hum Retrovir. 2017;33:1–10.

    Article  CAS  PubMed  Google Scholar 

  • Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA, CGC, Freedman-Cass DA. AIDS-related Kaposi sarcoma, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2019;17:171–89.

    Article  Google Scholar 

  • Ruocco E, Ruocco V, Tornesello ML, Gambardella A, Wolf R, Buonaguro FM. Kaposi’s sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin Dermatol. 2013;31:413–22.

    Article  PubMed  PubMed Central  Google Scholar 

  • Singh NB, Lakier RH, Donde B. Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma—a prospective randomized trial. Radiother Oncol. 2008;88:211–6.

    Article  PubMed  Google Scholar 

  • Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, Chirlaque MD, Marcos-Gragera R, Visser O, Serraino D, Weiderpass E, Dei Tos AP, Ascoli V, RARECARE Working Group. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project. Cancer Epidemiol. 2014;38:670–8.

    Article  CAS  PubMed  Google Scholar 

  • Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomark Prev. 2016;25:16–27.

    Article  Google Scholar 

  • Tsao MN, Sinclair E, Assaad D, Fialkov J, Antonyshyn O, Barnes E. Radiation therapy for the treatment of skin Kaposi sarcoma. Ann Palliat Med. 2016;5:298–302.

    Article  PubMed  Google Scholar 

  • Uldrick TS, Wyvill KM, Kumar P, O’Mahony D, Bernstein W, Aleman K, et al. Phase II study of bevacizumab in patients with HIV-associated Kaposi’s sarcoma receiving antiretroviral therapy. J Clin Oncol. 2012;30:1476–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vangipuram R, Tyring SK. Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant. Int J Dermatol. 2019;58:538–42.

    Article  PubMed  Google Scholar 

  • Vassallo C, Carugno A, Derlino F, Ciocca O, Brazzelli V, Borroni G. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients. Cutis. 2015;95:E28–34.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy

    Ketty Peris

  2. UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy

    Ketty Peris & Laura Del Regno

Authors
  1. Ketty Peris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Del Regno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ketty Peris .

Editor information

Editors and Affiliations

  1. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Andreas D. Katsambas

  2. Research Center CSRMR, Marconi University, Rome, Roma, Italy

    Torello M. Lotti

  3. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Clio Dessinioti

  4. Dermatoloy Unit, Livorno Hospital, Livorno, Italy

    Angelo Massimiliano D'Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Peris, K., Del Regno, L. (2023). Kaposi’s Sarcoma. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation